The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s immunoglobulins market report forecasts the immunoglobulins market size to grow to XX Billion by 2027, with a CAGR (compound annual growth rate) of almost 9%.

Learn More On The Immunoglobulins Market Report 2023 – https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Immunoglobulins Market Size Forecast
The global immunoglobulins market is expected to grow from $15.89 billion in 2022 to $17.16 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The immunoglobulins market size is expected to grow to $24.1 billion in 2027 at a CAGR of 8.9%.

North America held the largest immunoglobulins market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Immunoglobulins Market Driver ­– Increase In The Geriatric Population
According to the United Nations department of economic and social affairs (UN DESA), in 2020, the number of people aged over 65 was 727 million globally. By 2050, this figure is expected to have more than doubled, reaching over 1.5 billion people. The aging population is expected to rise from 9.3% in 2020 to 16% in 2050. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.

Request for A Sample Of The Global Immunoglobulins Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

Key Immunoglobulins Market Trend – Launching New Offices And Laboratories
The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, has opened offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological illnesses. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV platform and antibody-based targeted degradation technology. The company is developing a pipeline of new vectorized antibodies to treat muscle and CNS illnesses, to enhance delivery, durability, and accessibility of specific tissues and cells, to overcome the limits of present therapies.

Immunoglobulins Market Segment
1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Immunoglobulins Market Major Players and Strategies
Major players in the immunoglobulins market are Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma, China Biologic Products Inc., Kedrion S.p.A., LFB group, Biotest AG, Sanquin, ADMA Biologics, Option Care Enterprises, and Shanghai Raas Blood Products Co. Ltd.

In June 2020, CSL Behring, a US-based biopharmaceutical company acquired Vitaeris Inc., for an undisclosed amount. This acquisition accelerates the addition of clazakizumab, an anti-IL6 MAB currently in phase III development for the treatment of chronic active antibody-mediated rejection, into CSL Behring’s portfolio. Vitaeris Inc., is a US-based clinical-stage biotechnology company.

The Immunoglobulins Global Market Report 2023 covers regional data on immunoglobulins market size, immunoglobulins market trends and drivers, opportunities, strategies, and immunoglobulins market competitor analysis. The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, like viruses or bacteria, and assisting in their eradication.

View More Reports Related To The Immunoglobulins Market –
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2023
Immunosuppressants Global Market Report 2023
Autoimmune Disease Diagnosis Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: